total | XIAP low | XIAP high | p | ||||
---|---|---|---|---|---|---|---|
n | % | n | % | n | % | ||
number of patients | 311 | 100 | 267 | 85.9 | 44 | 14.1 | |
sex | |||||||
female | 32 | 10.3 | 29 | 90.6 | 3 | 9.4 | 0.593 |
male | 279 | 89.7 | 238 | 85.3 | 41 | 14.7 | |
age at diagnosis | 62.1 | 66.3 | 0.032 | ||||
initial T stage (a) | |||||||
pT1 | 25 | 8.1 | 21 | 84 | 4 | 16 | 0.151 |
pT2 | 29 | 9.4 | 29 | 100 | 0 | 0 | |
pT3 | 250 | 80.6 | 211 | 84.4 | 39 | 15.6 | |
pT4 | 6 | 1.9 | 5 | 83.3 | 1 | 16.7 | |
initial N stage (a) | |||||||
pN0 | 126 | 40.6 | 104 | 82.5 | 22 | 17.5 | 0.260 |
pN1 | 113 | 36.5 | 101 | 89.4 | 12 | 10.6 | |
pN2 | 36 | 11.6 | 29 | 80.6 | 7 | 19.4 | |
pN3 | 35 | 11.3 | 32 | 91.4 | 3 | 8.6 | |
Grading | |||||||
G1 | 3 | 1.4 | 3 | 100 | 0 | 0 | 0.539 |
G2 | 136 | 62.4 | 112 | 82.4 | 24 | 17.6 | |
G3 | 78 | 35.8 | 69 | 88.5 | 9 | 11.5 | |
G4 | 1 | 0.5 | 1 | 100 | 0 | 0 | |
R status (c) | |||||||
R0 | 206 | 66.2 | 175 | 85 | 31 | 15 | 0.424 |
R1 | 16 | 5.1 | 14 | 87.5 | 2 | 12.5 | |
R2 | 2 | 0.6 | 1 | 50 | 1 | 50 | |
neoadjuvant therapy (b) | |||||||
yes | 185 | 60.3 | 165 | 89.2 | 20 | 10.8 | 0.064 |
no | 122 | 39.7 | 99 | 81.1 | 23 | 18.9 | |
type of neoadj. Therapy (‘) | |||||||
Rctx | 107 | 93 | 86 | 80.4 | 21 | 19.6 | 0.620 |
Ctx | 8 | 7 | 7 | 87.5 | 1 | 12.5 |